Literature DB >> 29241546

Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.

Julien Faget1, Svenja Groeneveld1, Gael Boivin2, Martial Sankar3, Nadine Zangger4, Miguel Garcia5, Nicolas Guex3, Inti Zlobec6, Loïc Steiner1, Alessandra Piersigilli7, Ioannis Xenarios3, Etienne Meylan8.   

Abstract

Understanding the immune compartment of tumors facilitates the development of revolutionary new therapies. We used a Kras(G12D)-driven mouse model of lung cancer to establish an immune signature and identified a contribution of Gr1+ neutrophils to disease progression. Depletion experiments showed that Gr1+ cells (1) favor tumor growth, (2) reduce T cell homing and prevent successful anti-PD1 immunotherapy, and (3) alter angiogenesis, leading to hypoxia and sustained Snail expression in lung cancer cells. In turn, Snail accelerated disease progression and increased intratumoral Cxcl2 secretion and neutrophil infiltration. Cxcl2 was produced mainly by neutrophils themselves in response to a factor secreted by Snail-expressing tumor cells. We therefore propose a vicious cycle encompassing neutrophils and Snail to maintain a deleterious tumor microenvironment.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCL2; MegaClust; PD1; Snail; hypoxia; immune exclusion; immunotherapy; lung cancer; neutrophil; vascularization

Mesh:

Substances:

Year:  2017        PMID: 29241546     DOI: 10.1016/j.celrep.2017.11.052

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  63 in total

1.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

2.  Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.

Authors:  Yao Zhang; Na Diao; Christina K Lee; Hong Wei Chu; Lan Bai; Liwu Li
Journal:  Mol Ther       Date:  2019-09-23       Impact factor: 11.454

3.  Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models.

Authors:  Amaia Martinez-Usatorre; Ece Kadioglu; Gael Boivin; Chiara Cianciaruso; Alan Guichard; Bruno Torchia; Nadine Zangger; Sina Nassiri; Ioanna Keklikoglou; Martina Schmittnaegel; Carola H Ries; Etienne Meylan; Michele De Palma
Journal:  Sci Transl Med       Date:  2021-08-11       Impact factor: 17.956

Review 4.  Chemokines and the immune response to cancer.

Authors:  Aleksandra J Ozga; Melvyn T Chow; Andrew D Luster
Journal:  Immunity       Date:  2021-04-10       Impact factor: 31.745

Review 5.  Neutrophils in cancer-unresolved questions.

Authors:  Melissa S F Ng; Leonard Tan; Quanbo Wang; Charles R Mackay; Lai Guan Ng
Journal:  Sci China Life Sci       Date:  2021-02-24       Impact factor: 6.038

Review 6.  The Immune Microenvironment and Cancer Metastasis.

Authors:  Asmaa El-Kenawi; Kay Hänggi; Brian Ruffell
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

7.  Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.

Authors:  Kartik Sehgal; Andrew Portell; Elena V Ivanova; Patrick H Lizotte; Navin R Mahadevan; Jonathan R Greene; Amir Vajdi; Carino Gurjao; Tyler Teceno; Luke J Taus; Tran C Thai; Shunsuke Kitajima; Derek Liu; Tetsuo Tani; Moataz Noureddine; Christie J Lau; Paul T Kirschmeier; David Liu; Marios Giannakis; Russell W Jenkins; Prafulla C Gokhale; Silvia Goldoni; Maria Pinzon-Ortiz; William D Hastings; Peter S Hammerman; Juan J Miret; Cloud P Paweletz; David A Barbie
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 8.  Neutrophils in cancer: heterogeneous and multifaceted.

Authors:  Catherine C Hedrick; Ilaria Malanchi
Journal:  Nat Rev Immunol       Date:  2021-07-06       Impact factor: 53.106

Review 9.  Neutrophil dynamics in the tumor microenvironment.

Authors:  Amanda J McFarlane; Frédéric Fercoq; Seth B Coffelt; Leo M Carlin
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 10.  Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option.

Authors:  Justin K Messex; Geou-Yarh Liou
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.